Cost-effectiveness of tyrosine kinase inhibitor treatment strategies for chronic myeloid leukemia in chronic phase after generic entry of imatinib in the United States
Nom du journal : J Natl Cancer Inst
Année : 2016
Volume : 108
Page de départ : 108 (7)